| Literature DB >> 26990093 |
Shaun Scholes1, Sally Bridges2, Linda Ng Fat1, Jennifer S Mindell1.
Abstract
BACKGROUND: The Physical Activity and Sedentary Behaviour Assessment Questionnaire (PASBAQ), used within the Health Survey for England (HSE) at 5-yearly intervals, is not included annually due to funding and interview-length constraints. Policy-makers and data-users are keen to consider shorter instruments such as the Short-form International Physical Activity Questionnaire (IPAQ) for the annual survey. Both questionnaires were administered in HSE 2012, enabling comparative assessment in a random sample of 1252 adults.Entities:
Mesh:
Year: 2016 PMID: 26990093 PMCID: PMC4798726 DOI: 10.1371/journal.pone.0151647
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Structure and content of the physical activity questionnaires (PASBAQ and Short-form IPAQ) used in HSE 2012.
| Structure and content | PASBAQ | Short-form IPAQ |
|---|---|---|
| Interview | Nurse visit | |
| ~12 minutes | ~2 minutes | |
| Detailed module | 7 questions | |
| Last 28 days | Last 7 days | |
| 10 minutes | 10 minutes | |
| Housework; manual/gardening/do-it-yourself; walking; sports/exercise | Walking | |
| Showcards and activities read out by a respondent and coded in the interview from a list in the interview programme | Examples | |
| Subset of sports/exercise (as indexed by MET compendium) and follow-up question on whether activity had made participants “out-of-breath or sweaty” | Frequency and duration of: “activities that take hard physical effort and make you breathe much harder than normal. Examples include heavy lifting, digging, aerobics, fast bicycling.” | |
| (1) “Heavy” housework (e.g., digging, refitting a kitchen/bathroom) | (1) Frequency and duration of: “activities that take moderate physical effort and make you breathe somewhat harder than normal. Examples include carrying light loads, bicycling at a regular pace, doubles tennis.” | |
| (2) “Heavy” manual (e.g., moving heavy furniture, cleaning windows) | ||
| (3) Walking of at least moderate-intensity (see below) | (2) All walking (see below) | |
| (4) Subset of sports/exercise (as indexed by MET compendium) and follow-up question on whether activity had made participants “out-of-breath or sweaty” | ||
| Includes walking to and from work, and all other walking done for recreation, sport, exercise, or leisure. | Frequency and duration of walking which “includes at work and at home, walking to travel from place to place, and any other walking that you have done solely for recreation, sport, exercise, or leisure”. | |
| Participants who reported fairly brisk/fast-paced walking (≥16 years), and for whom the pace of walking was slow/average-paced but for whom the effort was usually enough to make them “breathe faster, feel warmer, or sweat” (aged ≥65 years) | Intensity of walking not assessed. | |
| Non-occupational sitting: (1) Television-viewing (weekday, weekend days); (2) Non-television-viewing (weekday, weekend days) | Sitting on weekdays including “time spent at work, at home, while doing course work and during leisure time. This may include time spent sitting at a desk, visiting friends, reading, or sitting or lying down to watch television.” |
IPAQ, International Physical Activity Questionnaire; MET, metabolic equivalent; MVPA, moderate-to-vigorous physical activity; PA, physical activity; PASBAQ, Physical Activity and Sedentary Behaviour Assessment Questionnaire
Derivation of summary variables (PASBAQ and IPAQ) used in HSE 2012.
| Variable | PASBAQ | Short-form IPAQ |
|---|---|---|
| MVPA ≥150minutes/week (including moderate-intensity walking) | MVPA ≥150minutes/week (all walking included) | |
| (1) MVPA ≥150minutes/week (excluding moderate-intensity walking); (2) MVPA ≥150minutes/week (excluding occupational activity) | (1) MVPA ≥150minutes/week (excluding all walking); (2) MVPA ≥150minutes/week (excluding occupational activity) | |
| MVPA <30minutes/week (including moderate-intensity walking) | MVPA <30minutes/week (all walking included) | |
| MVPA <30minutes/week (excluding moderate-intensity walking) | MVPA <30minutes/week (excluding all walking) | |
| Sitting down ≥540minutes/weekday | Sitting down ≥540minutes/weekday |
IPAQ, International Physical Activity Questionnaire; MVPA, moderate-to-vigorous physical activity; PASBAQ, Physical Activity and Sedentary Behaviour Assessment Questionnaire
Characteristics of participants in the Health Survey for England 2012 by sample type (PASBAQ without IPAQ and PASBAQ with IPAQ).
| Characteristic | PASBAQ without IPAQ ( | PASBAQ with IPAQ ( | |||
|---|---|---|---|---|---|
| % | Mean (SD) | % | Mean (SD) | ||
| 49.0 | 48.0 | 0.413 | |||
| 46.0 (18.9) | 49.1 (18.1) | <0.001 | |||
| 16–44 | 50.0 | 41.4 | <0.001 | ||
| 45–64 | 30.9 | 37.2 | |||
| 65+ | 19.2 | 21.4 | |||
| Married/cohabiting | 61.5 | 63.6 | 0.024 | ||
| Single | 24.5 | 20.1 | |||
| Other | 14.0 | 16.3 | |||
| Missing | 0.0 | - | |||
| Managerial and professional | 32.0 | 33.7 | 0.243 | ||
| Intermediate | 23.4 | 24.5 | |||
| Routine and manual | 36.4 | 36.0 | |||
| Other | 6.4 | 4.5 | |||
| Missing | 1.8 | 1.3 | |||
| 27.1 (5.3) | 27.3 (5.3) | 0.477 | |||
| Under 18.5 | 1.5 | 1.0 | 0.444 | ||
| 18.5 and below 25 | 29.9 | 34.3 | |||
| 25 and below 30 | 30.6 | 33.7 | |||
| 30 and below 40 | 18.0 | 21.9 | |||
| Over 40 | 2.0 | 2.2 | |||
| Missing | 17.9 | 7.0 | |||
| 52.8 (13.8) | 53.4 (14.2) | 0.328 | |||
| Lowest | 16.8 | 30.2 | 0.276 | ||
| Middle | 17.6 | 29.3 | |||
| Highest | 12.6 | 24.6 | |||
| Missing | 53.1 | 15.9 | |||
| Highest | 27.2 | 29.7 | 0.138 | ||
| Middle | 26.0 | 29.8 | |||
| Lowest | 25.4 | 22.6 | |||
| Missing | 21.4 | 17.8 | |||
| 60.8 | 63.3 | 0.181 | |||
| 9.1 | 8.7 | 0.652 | |||
| 20.3 | 17.3 | 0.114 | |||
| 16.2 | 17.9 | 0.623 | |||
| 10.5 | 11.0 | 0.627 | |||
| 24.8 | 26.3 | 0.417 | |||
| 60.7 | 63.4 | 0.238 | |||
| 10.2 | 10.5 | 0.839 | |||
The Physical Activity and Sedentary Behaviour Assessment Questionnaire (PASBAQ) was administered in the interview; the Short-form International Physical Activity Questionnaire (IPAQ) was administered in the nurse visit. Sample counts un-weighted. Estimates were weighted by the interview-weight variable. Column percentages may not sum to 100 because of rounding error.
BMI, body mass index; bpm, beats per minute; CVD, cardiovascular disease; MVPA, moderate-to-vigorous physical activity; NS-SEC, National Statistics Socio-Economic Classification; SD, standard deviation; WEMWBS, Warwick-Edinburgh Mental Well-Being Scale.
a P-values calculated by means of the χ2 test (categorical variables) or t-test (continuous variables).
b Sex-specific cut-points for defining the heart rate tertiles: Men (24.0–49.5; 50.0–60.5; 61.0–119.0 bpm); Women (1.0–43.5; 44.0–56.5; 57.0–168.0 bpm).
Fig 1Relationships between PASBAQ and IPAQ assessed MVPA for men (left panel) and women (right panel).
Solid line represents the fitted linear regression line; dotted line represents the 45 degree line of equality (indicating perfect agreement). Pearson (r) and concordance (Pc) correlation coefficients shown.
Fig 2Relationships between PASBAQ and IPAQ assessed time spent sitting on weekdays for men (left panel) and women (right panel).
Solid line represents the fitted linear regression line; dotted line represents the 45 degree line of equality (indicating perfect agreement). Pearson (r) and concordance (Pc) correlation coefficients shown.
Fig 3Prevalence of sufficient aerobic activity, inactivity, and excessive sitting according to the PASBAQ and Short-form IPAQ.
Proportion of participants categorised as: (1) sufficiently aerobically active (moderate-to-vigorous physical activity [MVPA] ≥150minutes/week), 2) inactive (MVPA <30minutes/week), and 3) sedentary (sitting ≥540minutes/weekday) according to the Physical Activity and Sedentary Behaviour Assessment Questionnaire (PASBAQ) and Short-form International Physical Activity Questionnaire (IPAQ) across groups stratified by gender, age-group, income, resting pulse rate (RHR), and BMI category.
Kappa statistic and 95% CI, and the prevalence-adjusted bias-adjusted Kappa (PABAK) statistic for PASBAQ- and IPAQ-based estimates of sufficient aerobic activity, inactivity, and excessive sitting.
| Sufficient activity | Inactivity | Excessive sitting | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| (MVPA ≥150minutes/week) | (MVPA <30minutes/week) | (≥540minutes/weekday) | |||||||||||||
| Kappa (95% CI) | Kmax | PABAK | PI | BI | Kappa (95% CI) | Kmax | PABAK | PI | BI | Kappa (95% CI) | Kmax | PABAK | PI | BI | |
| 0.31 (0.26–0.37) | 0.65 | 0.42 | -0.43 | 0.15 | 0.26 (0.20–0.33) | 0.64 | 0.62 | 0.70 | -0.09 | 0.15 (0.08–0.22) | 0.61 | 0.60 | 0.74 | 0.09 | |
| Men | 0.32 (0.23–0.41) | 0.70 | 0.49 | -0.51 | 0.11 | 0.32 (0.22–0.42) | 0.71 | 0.68 | 0.73 | -0.07 | 0.11 (0.02–0.20) | 0.50 | 0.58 | 0.74 | 0.12 |
| Women | 0.30 (0.23–0.37) | 0.60 | 0.36 | -0.35 | 0.18 | 0.21 (0.13–0.30) | 0.59 | 0.55 | 0.66 | -0.12 | 0.20 (0.10–0.30) | 0.71 | 0.63 | 0.74 | 0.07 |
| 16–44 | 0.23 (0.13–0.33) | 0.58 | 0.49 | -0.60 | 0.14 | 0.03 (0.00–0.11) | 0.42 | 0.72 | 0.85 | -0.08 | 0.10 (0.00–0.21) | 0.57 | 0.57 | 0.73 | 0.10 |
| 45–64 | 0.32 (0.23–0.41) | 0.69 | 0.40 | -0.37 | 0.14 | 0.27 (0.16–0.39) | 0.72 | 0.60 | 0.67 | -0.08 | 0.06 (0.00–0.15) | 0.39 | 0.59 | 0.77 | 0.13 |
| 65+ | 0.33 (0.23–0.42) | 0.63 | 0.32 | -0.14 | 0.19 | 0.32 (0.21–0.42) | 0.66 | 0.42 | 0.40 | -0.15 | 0.43 (0.30–0.57) | 0.97 | 0.71 | 0.69 | -0.01 |
| Normal | 0.30 (0.20–0.41) | 0.64 | 0.49 | -0.53 | 0.13 | 0.24 (0.10–0.38) | 0.63 | 0.74 | 0.82 | -0.06 | 0.01 (0.00–0.12) | 0.60 | 0.55 | 0.75 | 0.09 |
| Overweight | 0.26 (0.16–0.35) | 0.60 | 0.42 | -0.49 | 0.15 | 0.17 (0.06–0.27) | 0.60 | 0.60 | 0.72 | -0.10 | 0.24 (0.10–0.37) | 0.60 | 0.69 | 0.78 | 0.08 |
| Obese | 0.27 (0.16–0.38) | 0.65 | 0.32 | -0.30 | 0.16 | 0.21 (0.08–0.33) | 0.66 | 0.49 | 0.60 | -0.11 | 0.07 (0.00–0.19) | 0.54 | 0.53 | 0.71 | 0.12 |
| Highest | 0.18 (0.07–0.29) | 0.73 | 0.42 | -0.55 | 0.10 | 0.16 (0.03–0.29) | 0.64 | 0.72 | 0.82 | -0.06 | 0.05 (0.00–0.11) | 0.14 | 0.49 | 0.71 | 0.23 |
| Middle | 0.30 (0.20–0.40) | 0.62 | 0.41 | -0.42 | 0.16 | 0.19 (0.07–0.31) | 0.64 | 0.59 | 0.71 | -0.09 | 0.26 (0.08–0.43) | 0.82 | 0.75 | 0.81 | 0.03 |
| Lowest | 0.41 (0.31–0.52) | 0.62 | 0.48 | -0.38 | 0.17 | 0.41 (0.29–0.53) | 0.64 | 0.63 | 0.62 | -0.11 | 0.22 (0.07–0.37) | 0.92 | 0.63 | 0.72 | 0.02 |
| Lowest | 0.26 (0.15–0.37) | 0.65 | 0.41 | -0.48 | 0.14 | 0.14 (0.01–0.27) | 0.59 | 0.65 | 0.77 | -0.09 | 0.12 (0.00–0.23) | 0.38 | 0.61 | 0.76 | 0.14 |
| Middle | 0.29 (0.18–0.39) | 0.60 | 0.43 | -0.47 | 0.16 | 0.24 (0.12–0.37) | 0.63 | 0.64 | 0.73 | -0.09 | 0.19 (0.04–0.34) | 0.68 | 0.62 | 0.73 | 0.08 |
| Highest | 0.40 (0.30–0.49) | 0.68 | 0.43 | -0.30 | 0.15 | 0.32 (0.21–0.43) | 0.64 | 0.52 | 0.56 | -0.12 | 0.24 (0.09–0.38) | 0.68 | 0.67 | 0.76 | 0.07 |
BI, bias-index; BMI, body mass index; CI, confidence interval; IPAQ, Short-form International Physical Activity Questionnaire; κmax, maximum attainable value of the Kappa statistic; MVPA, moderate-to-vigorous physical activity; PABAK, prevalence-adjusted bias-adjusted Kappa statistic; PASBAQ, physical activity and sedentary behaviour questionnaire; PI, prevalence-index.
Bias-index denotes the difference between disagreements; Prevalence-index denotes the difference between agreements on the positive and negative classification.
a PASBAQ-defined sufficient aerobic activity and inactivity included walking of at least moderate-intensity only; IPAQ-defined sufficient aerobic activity and inactivity included all walking as the intensity of walking was not assessed.
Percentage agreement and weighted Kappa coefficients for PASBAQ- and IPAQ-based tertiles of MVPA and of sitting.
| N | Tertiles of time spent in MVPA | Tertiles of time spent sitting | |
|---|---|---|---|
| % agreement, weighted Kappa (95% CI) | |||
| 1252 | 48.4%, 0.39 (0.34–0.43) | 44.2%, 0.22 (0.16–0.27) | |
| Men | 548 | 49.6%, 0.41 (0.32–0.46) | 43.0%, 0.15 (0.07–0.24) |
| Women | 704 | 47.1%, 0.37 (0.28–0.43) | 45.3%, 0.27 (0.21–0.34) |
| 16–44 | 427 | 48.9%, 0.37 (0.30–0.47) | 45.1%, 0.19 (0.12–0.31) |
| 45–64 | 477 | 47.8%, 0.38 (0.32–0.44) | 40.8%, 0.13 (0.01–0.23) |
| 65+ | 348 | 48.0%, 0.35 (0.25–0.42) | 48.1%, 0.35 (0.24–0.41) |
| Normal | 407 | 47.9%, 0.40 (0.31–0.48) | 43.0%, 0.21 (0.12–0.36) |
| Overweight | 435 | 47.2%, 0.31 (0.21–0.39) | 43.9%, 0.19 (0.08–0.36) |
| Obese | 302 | 46.8%, 0.37 (0.28–0.48) | 46.3%, 0.23 (0.12–0.34) |
| Highest | 366 | 41.8%, 0.33 (0.28–0.43) | 38.6%, 0.12 (0.05–0.18) |
| Middle | 361 | 51.4%, 0.39 (0.28–0.47) | 47.9%, 0.30 (0.19–0.41) |
| Lowest | 307 | 47.8%, 0.41 (0.35–0.56) | 50.2%, 0.35 (0.27–0.46) |
| Lowest | 352 | 47.7%, 0.39 (0.27–0.47) | 42.5%, 0.12 (0.06–0.21) |
| Middle | 358 | 52.9%, 0.42 (0.33–0.49) | 41.3%, 0.22 (0.12–0.34) |
| Highest | 350 | 47.2%, 0.41 (0.32–0.48) | 45.8%, 0.30 (0.20–0.37) |
BMI, body mass index; CI, confidence interval; IPAQ, Short-form International Physical Activity Questionnaire; MVPA, moderate-to-vigorous physical activity; PASBAQ, Physical Activity and Sedentary Behaviour Assessment Questionnaire.
Counts are unweighted: estimates weighted.
Fig 4Prevalence of health outcomes according to the PASBAQ- and Short-form IPAQ-assessed tertiles of time spent in MVPA for men (top panel) and women (lower panel).
Proportion of participants categorised with physical health and mental health outcomes according to the Physical Activity and Sedentary Behaviour Assessment Questionnaire (PASBAQ) and Short-form International Physical Activity Questionnaire (IPAQ) assessed tertiles of time spent in Moderate to Vigorous Physical Activity (MVPA).
Associations of PASBAQ- and IPAQ-assessed time spent in moderate-to-vigorous intensity physical activity with odds of unfavourable health outcomes.
| Health outcomes | PASBAQ-MVPA | IPAQ-MVPA | PASBAQ and IPAQ | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Middle | Highest | Middle | Highest | ||||||
| Odds ratio (95% CI) | Odds ratio (95% CI) | ||||||||
| Raised cholesterol | 0.83 (0.34–2.01) | 0.80 (0.33–1.98) | 0.889 | 0.637 | 0.61 (0.34–1.07) | 0.70 (0.41–1.18) | 0.191 | 0.252 | 0.063 |
| Obese | 0.56 (0.28–1.09) | 0.75 (0.37–1.49) | 0.230 | 0.485 | 0.39 (0.18–0.84) | 0.68 (0.31–1.47) | 0.036 | 0.395 | 0.813 |
| Hypertension | 0.96 (0.56–1.63) | 0.99 (0.58–1.68) | 0.985 | 0.973 | 0.95 (0.52–1.72) | 0.92 (0.50–1.71) | 0.965 | 0.791 | 0.991 |
| Current smoker | 1.47 (0.76–2.82) | 1.05 (0.57–1.95) | 0.434 | 0.998 | 1.45 (0.78–2.72) | 1.48 (0.81–2.68) | 0.399 | 0.206 | 0.620 |
| Above alcohol limits | 1.28 (0.61–2.68) | 1.08 (0.55–2.09) | 0.769 | 0.886 | 0.73 (0.29–1.85) | 0.95 (0.36–2.46) | 0.599 | 0.937 | 0.473 |
| Low WEMWBS | 0.40 (0.18–0.89) | 0.21 (0.07–0.58) | 0.007 | 0.003 | 0.39 (0.16–0.94) | 0.73 (0.31–1.71) | 0.114 | 0.530 | 0.132 |
| Self-reported CVD | 1.29 (0.73–2.29) | 0.75 (0.36–1.58) | 0.353 | 0.370 | 0.72 (0.37–1.40) | 0.52 (0.25–1.06) | 0.193 | 0.069 | 0.393 |
| Raised cholesterol | 1.04 (0.56–1.93) | 1.10 (0.64–1.90) | 0.941 | 0.726 | 1.36 (0.79–2.33) | 1.03 (0.57–1.88) | 0.381 | 0.941 | 0.753 |
| Obese | 1.03 (0.65–1.62) | 0.44 (0.27–0.73) | 0.001 | 0.001 | 0.58 (0.37–0.93) | 0.52 (0.33–0.83) | 0.016 | 0.007 | 0.289 |
| Hypertension | 1.41 (0.91–2.19) | 0.87 (0.47–1.61) | 0.134 | 0.602 | 0.73 (0.44–1.22) | 0.99 (0.61–1.62) | 0.394 | 0.984 | 0.839 |
| Current smoker | 0.49 (0.23–1.04) | 0.81 (0.40–1.65) | 0.166 | 0.604 | 0.41 (0.20–0.86) | 1.01 (0.55–1.86) | 0.022 | 0.951 | 0.546 |
| Above alcohol limits | 1.45 (0.77–2.71) | 1.29 (0.67–2.48) | 0.507 | 0.469 | 1.02 (0.53–1.98) | 0.68 (0.35–1.32) | 0.312 | 0.253 | 0.162 |
| Low WEMWBS | 0.68 (0.35–1.30) | 0.45 (0.21–0.98) | 0.132 | 0.043 | 0.40 (0.20–0.83) | 0.39 (0.21–0.70) | 0.005 | 0.003 | 0.083 |
| Self-reported CVD | 0.65 (0.37–1.15) | 0.43 (0.17–1.10) | 0.163 | 0.069 | 0.52 (0.27–0.99) | 0.70 (0.37–1.33) | 0.134 | 0.285 | 0.207 |
CI, confidence interval, CVD, cardiovascular disease; IPAQ, Short-form International Physical Activity Questionnaire; MVPA, moderate-to-vigorous physical activity; PASBAQ, Physical Activity and Sedentary Behaviour Assessment Questionnaire; WEMWBS Warwick-Edinburgh Mental Well-Being Scale.
Estimates age-standardised using the 2012 English household population.
a Odds ratios obtained using logistic regression, with the health outcome as dependent variable and tertiles of MVPA as a categorical variable (lowest group as the reference).
b P-value for trend obtained using logistic regression, with the health outcome as dependent variable and tertiles of MVPA entered as a single continuous independent variable.
c PASBAQ- and IPAQ-MVPA included in the same model (adjusted for age) as continuous independent variables; P-value shown is the test for statistical interaction.
Fig 5Associations of PASBAQ- and IPAQ-assessed time spent in MVPA with odds of unfavourable health outcomes for men (top panel) and women (lower panel).
The odds ratios (and 95% CI) shown in Table 6 are shown in graphical form. The estimates compare participants in: (1) the middle tertile of MVPA vs. the lowest tertile of MVPA (dark grey), and (2) the highest tertile of MVPA vs. the lowest tertile of MVPA (light grey), grouped by health outcome.
Fig 6Prevalence of health outcomes according to the PASBAQ- and Short-form IPAQ-assessed tertiles of time spent sitting for men (top panel) and for women (lower panel).
Proportion of participants categorised with physical health and mental health outcomes according to the Physical Activity and Sedentary Behaviour Assessment Questionnaire (PASBAQ) and Short-form International Physical Activity Questionnaire (IPAQ) assessed tertiles of time spent sitting on weekdays.
Associations of PASBAQ- and IPAQ-assessed time spent sitting on weekdays with odds of unfavourable health outcomes.
| Health outcomes | PASBAQ-sitting time | IPAQ-sitting time | PASBAQ and IPAQ | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Middle | Highest | Middle | Highest | ||||||
| Odds ratio (95% CI) | Odds ratio (95% CI) | ||||||||
| Raised cholesterol | 1.06 (0.58–1.96) | 0.69 (0.34–1.39) | 0.419 | 0.324 | 1.13 (0.58–2.19) | 0.90 (0.48–1.71) | 0.769 | 0.689 | 0.713 |
| Obese | 1.14 (0.59–2.20) | 1.98 (0.97–4.02) | 0.136 | 0.063 | 0.85 (0.45–1.61) | 1.07 (0.57–2.03) | 0.716 | 0.767 | 0.366 |
| Hypertension | 1.26 (0.73–2.17) | 1.53 (0.89–2.63) | 0.299 | 0.119 | 0.97 (0.54–1.76) | 0.73 (0.40–1.36) | 0.476 | 0.294 | 0.296 |
| Current smoker | 0.65 (0.31–1.36) | 1.74 (0.88–3.44) | 0.007 | 0.135 | 0.82 (0.41–1.65) | 0.82 (0.37–1.83) | 0.847 | 0.662 | 0.066 |
| Above alcohol limits | 1.39 (0.73–2.63) | 1.43 (0.74–2.75) | 0.466 | 0.286 | 1.17 (0.62–2.22) | 1.21 (0.68–2.15) | 0.801 | 0.530 | 0.438 |
| Low WEMWBS | 1.33 (0.46–3.83) | 2.56 (0.99–6.66) | 0.127 | 0.053 | 1.03 (0.40–2.66) | 1.76 (0.61–5.05) | 0.396 | 0.256 | 0.632 |
| Self-reported CVD | 2.26 (0.87–5.91) | 2.67 (1.04–6.87) | 0.124 | 0.032 | 1.24 (0.54–2.86) | 1.64 (0.72–3.74) | 0.450 | 0.214 | 0.134 |
| Raised cholesterol | 0.86 (0.43–1.72) | 0.74 (0.38–1.43) | 0.634 | 0.363 | 1.50 (0.83–2.74) | 1.15 (0.62–2.16) | 0.380 | 0.689 | 0.074 |
| Obese | 1.14 (0.63–2.06) | 1.85 (1.01–3.40) | 0.074 | 0.044 | 1.75 (1.07–2.86) | 1.83 (1.13–2.97) | 0.034 | 0.014 | 0.943 |
| Hypertension | 0.76 (0.39–1.48) | 1.37 (0.73–2.56) | 0.133 | 0.293 | 1.31 (0.78–2.19) | 1.06 (0.58–1.94) | 0.494 | 0.892 | 0.277 |
| Current smoker | 0.95 (0.48–1.88) | 1.41 (0.77–2.60) | 0.429 | 0.265 | 0.64 (0.34–1.20) | 0.54 (0.28–1.03) | 0.169 | 0.070 | 0.594 |
| Above alcohol limits | 0.69 (0.32–1.49) | 1.45 (0.74–2.86) | 0.082 | 0.257 | 0.64 (0.36–1.13) | 0.96 (0.49–1.88) | 0.257 | 0.960 | 0.132 |
| Low WEMWBS | 1.09 (0.49–2.45) | 2.10 (0.88–5.04) | 0.150 | 0.093 | 1.70 (0.75–3.85) | 2.77 (1.37–5.57) | 0.015 | 0.004 | 0.651 |
| Self-reported CVD | 1.27 (0.52–3.10) | 2.47 (1.16–5.26) | 0.014 | 0.012 | 1.54 (0.73–3.24) | 1.59 (0.72–3.49) | 0.470 | 0.241 | 0.815 |
CI, confidence interval, CVD, cardiovascular disease; IPAQ, Short-form International Physical Activity Questionnaire; MVPA, moderate-to-vigorous physical activity; PASBAQ, Physical Activity and Sedentary Behaviour Assessment Questionnaire; WEMWBS Warwick-Edinburgh Mental Well-Being Scale.
Estimates age-standardised using the 2012 English household population.
a Odds ratios obtained using logistic regression, with the health outcome as dependent variable and tertiles of MVPA as a categorical variable (lowest group as the reference).
b P-value for trend obtained using logistic regression, with the health outcome as dependent variable and tertiles of MVPA entered as a single continuous independent variable.
c PASBAQ- and IPAQ-MVPA included in the same model (adjusted for age) as continuous independent variables; P-value shown is the test for statistical interaction.
Fig 7Associations of PASBAQ- and IPAQ-assessed time spent sitting with odds of unfavourable health outcomes for men (top panel) and women (lower panel).
The odds ratios (and 95% CI) shown in Table 7 are shown in graphical form. The estimates compare participants in: (1) the middle tertile of sitting time vs. lowest tertile of sitting time (dark grey), and (2) the highest tertile of sitting time vs. lowest tertile of sitting time (light grey), grouped by health outcome.